SCNI

Scinai Immunotherapeutics
SCNI

Overview Fund Trends Analyst Outlook Journalist POV

5 hedge funds and large institutions have $7.09K invested in Scinai Immunotherapeutics in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
5
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.82K

Top Sellers

1
-$49.6K
2
-$627
3
-$278
4
MSG
Main Street Group
Virginia
-$59
5
GRP
Global Retirement Partners
California
-$14
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$5.85K
2
$880
3
$145
4
$110
5
$104
6
–
7
–
8
–
9
–